For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Bicycle Therapeutics PLC Sponsored (BCYC - Free Report) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
Bicycle Therapeutics PLC Sponsored is a member of the Medical sector. This group includes 899 individual stocks and currently holds a Zacks Sector Rank of #3. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. BCYC is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for BCYC's full-year earnings has moved 19.08% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
According to our latest data, BCYC has moved about 69.78% on a year-to-date basis. At the same time, Medical stocks have lost an average of 17.57%. This means that Bicycle Therapeutics PLC Sponsored is performing better than its sector in terms of year-to-date returns.
Breaking things down more, BCYC is a member of the Medical - Biomedical and Genetics industry, which includes 385 individual companies and currently sits at #97 in the Zacks Industry Rank. Stocks in this group have lost about 17.53% so far this year, so BCYC is performing better this group in terms of year-to-date returns.
BCYC will likely be looking to continue its solid performance, so investors interested in Medical stocks should continue to pay close attention to the company.